Inbiose
Universiteit Gent

Inbiose

Biotech
Biotech
Biotech
Biotech

Inbiose develops a fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs.

Inbiose was founded mid 2013 as a spin-off from Ghent University. Inbiose develops a versatile fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs. Specialty carbohydrates are high value added, rare and complex carbohydrates that are extremely hard to produce with conventional technologies (extraction, chemical or enzymatic synthesis). Though these powerful ingredients have been found to be essential for improving health in many areas, applications were hampered until today by the production cost and very limited availability. Inbiose can now tackle these technological issues, giving strong and reliable market perspectives.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
Trince
Qbic II
Biotech
Biotech
Biotech
Biotech

Trince

Trince developed a new transfection technology based on a combination of laser light and photothermal nanoparticles.

Universiteit Gent
EyeD Pharma
Qbic II
HealthTech
HealthTech
HealthTech
HealthTech

EyeD Pharma

EyeD Pharma is developing micro-implants for drug release over a prolonged period of time.

ULiège
VoxelSensors
Qbic III
Deeptech
Deeptech
Deeptech
Deeptech

VoxelSensors

VoxelSensors is developing ultra-low power and ultra-low latency 3D perception sensors for Extended Reality.

VUB